IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
37.02
+0.78 (2.15%)
At close: Aug 7, 2026, 4:00 PM EDT
36.95
-0.07 (-0.19%)
Pre-market: Aug 10, 2026, 8:20 AM EDT
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $3.57 billion as of August 10, 2026. Its market cap has increased by 72.48% in one year.
Market Cap
3.57B
Enterprise Value
2.36B
1-Year Change
72.48%
Ranking
Category
Stock Price
$37.02
ChartMarket Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $3.57B, an increase of 1,557.04%. That is a compound annual growth rate of 47.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 3.57B | 17.86% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 4.00B |
| Denali Therapeutics | 3.94B |
| Tango Therapeutics | 3.92B |
| Telix Pharmaceuticals | 3.89B |
| Structure Therapeutics | 3.78B |
| Arcus Biosciences | 3.64B |
| Alumis | 3.52B |
| Celldex Therapeutics | 3.27B |